- Komodo Health has signed a multi-year agreement with Blue Health Intelligence.
- Komodo Health wishes to upgrade its healthcare map with new features.
- The integration of data from Blue Health Intelligence can help Komodo Health to identify opportunities for early medical intervention, along with pinpointing clinical trial candidates.
Singing a new multi-year agreement, Komodo Health has forged a new partnership with Blue Health Intelligence. According to terms of deal, Komodo Health will integrate de-identified, longitudinal, real-world patient data from Blue Health Intelligence into its Healthcare Map that can track patient encounters across the US healthcare system.
Capturing patient journeys from more than 325 million de-identified individuals, the database will help healthcare stakeholders to understand many things including (but not limited to) gaps in care received by patients, identify opportunities for early medical intervention, and pinpoint clinical trial candidates.
In a statement, Dr. Arif Nathoo, the CEO and cofounder of Komodo Health, said that this partnership would enable life sciences companies to access Blue Health Intelligence and attain aggregated insights for the first time. When integrated into Komodo’s Healthcare Map, these insights are going to offer life sciences companies, the critical intelligence and real-world data that is necessary to truly understand what is happening in healthcare as advanced therapeutics as well as vaccines get developed.